Bisphosphonates Increase Contralateral Atypical Fracture Risk

Two words - Anabolic Clinic (sm).

Bisphosphonates are supposed to prevent fractures.

Patients who continue bisphosphonate therapy after an atypical index femur fracture are more likely to suffer a fracture in the contralateral femur, researchers reported here at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting.

"Stop bisphosphonates if you have an index atypical fracture," said lead researcher Richard M. Dell, MD, an orthopaedic surgeon at Kaiser Permanente, California.

Increasing evidence shows an association between bisphosphonate use and atypical femur fractures. Previous research found that more than 20% of patients with an index atypical femur fracture will develop an atypical femur fracture on the contralateral femur.

Oops.